Woerwag Pharma GmbH & Co. KG

Neurology and Peripheral Nerve Disorders

Research activity is centered on diabetic sensorimotor polyneuropathy, with attention to symptom relief in a chronic peripheral neuropathy associated with diabetes.

  • Diabetic sensorimotor polyneuropathy
  • Neuropathic symptoms
  • Peripheral nerve dysfunction

The sponsor’s clinical interest in this area reflects a focus on conditions affecting nerve sensation and motor function in people with diabetes.

The funded research addresses a complication of diabetes mellitus that affects the nervous system, highlighting therapeutic interest in managing long-term consequences of metabolic disease.

  • Diabetic complications
  • Metabolic nerve injury
  • Symptomatic management

This area links the sponsor’s clinical work to the treatment of diabetes-associated morbidity, particularly persistent sensory and motor complaints.

Pain and Symptom Management

Clinical interest extends to the treatment of neuropathic pain and related sensory disturbances, with emphasis on improving patient-reported symptoms in a chronic disorder.

  • Neuropathic pain
  • Sensory disturbances
  • Symptom burden

The research landscape includes therapies intended to address discomfort, altered sensation, and functional impairment linked to nerve damage.

Combination Treatment Strategies

The sponsor’s funded trial activity includes evaluation of combined therapy for symptomatic disease control, alongside comparison with single-agent treatment approaches.

  • Combined therapy
  • Monotherapy comparison
  • Therapeutic optimization

This focus places emphasis on identifying clinical options for patients whose symptoms remain difficult to manage with standard individual treatments.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of the effectiveness and safety of alpha-lipoic acid and benfotiamine for the treatment of symptoms in patients with diabetic neuropathy

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    Hungary